N/A
Completed N=20
Study to Evaluate the Efficacy of Removing Skin Tags With Digiclamp
Achrochordon
Source: ClinicalTrials.gov NCT03259295 ↗
Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Feb 2023
Primary outcomePrimary: Re-occurrence Rate of Skin Tags — 0 Participants
Summary
The objective of this study is to assess the efficacy of using the Digiclamp device to remove achrocordons (skin tags). The hypothesis is that utilizing the device will result in low rates of re-occurrence, scars, scar tissue and discoloration at the site of removal.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Re-occurrence Rate of Skin Tags |
— | — |
| SECONDARY Percentage of Permanent Scars Among Lesion Sites |
1 | — |
| SECONDARY Percentage of Scar Tissue Formation Among Lesion Sites |
— | — |
| SECONDARY Percentage of Discoloration Among Subjects |
3 | — |
| SECONDARY Percentage of Pain/Numbness Where Skin Tag Was Removed |
— | — |
| SECONDARY Satisfaction With Pain Post Procedure |
20; 0; 0; 0; 0 | — |
| SECONDARY Satisfaction With What the Area Looked Like Post Procedure |
19; 1; 0; 0; 0 | — |
| SECONDARY How Likely to Recommend the Procedure to Friends and Family |
20; 0; 0; 0; 0 | — |
Eligibility Criteria
Inclusion Criteria
- Subjects with simple skin tag(s) measuring up to 1 centimeter width at the base of the skin tag
Exclusion Criteria
- Subjects with skin tags measuring greater than 1 centimeter width at the base
- Subjects whose skin tags appear infected or may need to be evaluated by pathology
- Subjects whose skin tags are located in genital areas or eyelids
- Pregnant subjects
- Subjects with bleeding disorders.
Data sourced from ClinicalTrials.gov (NCT03259295). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.